Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hacene

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Cancer & Clinical Oncology|January 1, 1986
Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapyF Spyratos, J Oglobine, R Lidereau, et al.
Bulletin De L'Academie Nationale De Medecine|March 1, 1994
[Difficulties encountered in the evaluation of prognostic criteria of breast cancer: apropos of the experience of the René Huguenin center]F Spyratos, V Le Doussal, M Tubiana-Hulin, et al.
Breast Cancer Research and Treatment|November 1, 1989
Nuclear characteristics as indicators of prognosis in node negative breast cancer patientsV le Doussal, M Tubiana-Hulin, K Hacene, et al.
Cancer Research|June 1, 1983
Prognostic index for clinical Stage I cutaneous malignant melanomaK Hacene, V Le Doussal, M Brunet, et al.
The International Journal of Biological Markers|January 11, 2003
Prognostic value of CA 15.3 kinetics for metastatic breast cancerB De La Lande, K Hacene, J L Floiras, et al.
The International Journal of Biological Markers|April 14, 2004
Serum HER-2 extracellular domain: relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patientsM Saghatchian, S Guepratte, K Hacene, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 29, 2000
Comparison of Cyfra 21-1 and SCC assays in head and neck tumoursA Banal, K Hacene, E Berthelot-Ruff, et al.
Cancer|November 1, 1989
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomasV Le Doussal, M Tubiana-Hulin, S Friedman, et al.
Histopathology|January 1, 1984
Relationship between ultrastructure and receptor content of human primary breast cancerV Le Doussal, M F Pichon, C Pallud, et al.
Histopathology|September 1, 1993
Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumoursC Pallud, V Le Doussal, M F Pichon, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Cancer & Clinical Oncology|January 1, 1986
Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapyF Spyratos, J Oglobine, R Lidereau, et al.
Bulletin De L'Academie Nationale De Medecine|March 1, 1994
[Difficulties encountered in the evaluation of prognostic criteria of breast cancer: apropos of the experience of the René Huguenin center]F Spyratos, V Le Doussal, M Tubiana-Hulin, et al.
Breast Cancer Research and Treatment|November 1, 1989
Nuclear characteristics as indicators of prognosis in node negative breast cancer patientsV le Doussal, M Tubiana-Hulin, K Hacene, et al.
Cancer Research|June 1, 1983
Prognostic index for clinical Stage I cutaneous malignant melanomaK Hacene, V Le Doussal, M Brunet, et al.
The International Journal of Biological Markers|January 11, 2003
Prognostic value of CA 15.3 kinetics for metastatic breast cancerB De La Lande, K Hacene, J L Floiras, et al.
The International Journal of Biological Markers|April 14, 2004
Serum HER-2 extracellular domain: relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patientsM Saghatchian, S Guepratte, K Hacene, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 29, 2000
Comparison of Cyfra 21-1 and SCC assays in head and neck tumoursA Banal, K Hacene, E Berthelot-Ruff, et al.
Cancer|November 1, 1989
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomasV Le Doussal, M Tubiana-Hulin, S Friedman, et al.
Histopathology|January 1, 1984
Relationship between ultrastructure and receptor content of human primary breast cancerV Le Doussal, M F Pichon, C Pallud, et al.
Histopathology|September 1, 1993
Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumoursC Pallud, V Le Doussal, M F Pichon, et al.
Pageof 5